TrademarkDir
NEUROTRIM
LIVE

Serial Number

77715907

Owner

NEUROBRANDS, LLC

Attorney

Steve Hassid

First Use Date

Jul 2, 2009

Filing Date

Apr 17, 2009

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

NEUROTRIM Trademark

Serial Number: 77715907 • Registration: 3923701

NEUROTRIM is a trademark filed by NEUROBRANDS, LLC on April 17, 2009. The trademark is classified under Class 5 (Pharmaceuticals), Class 32 (Light Beverages). The application is currently registered and active.

Owner Contact Info

NEUROBRANDS, LLC (99 trademarks)

15303 Ventura Blvd Suite 675
Sherman Oaks, CA 91403

Entity Type: 16

Trademark Details

Filing Date

April 17, 2009

Registration Date

February 22, 2011

First Use Anywhere

July 2, 2009

First Use in Commerce

July 2, 2009

Published for Opposition

April 13, 2010

Goods & Services

Dietary and nutritional supplements; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary drink mix for use as a meal replacement; Dietary supplemental drinks; Dietary supplements for human consumption

Energy drinks; Fruit-flavoured beverages; Non-alcoholic beverages, namely, carbonated beverages; Sports drinks; Sports drinks, namely, energy drinks

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
May 13, 2021 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
May 13, 2021 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 13, 2021 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 13, 2021 APRE
TEAS SECTION 8 & 9 RECEIVED
Feb 3, 2021 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 22, 2020 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 4, 2018 TCCA
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 23, 2017 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 23, 2017 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 23, 2017 APRE
TEAS SECTION 8 & 15 RECEIVED
Jan 23, 2017 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 22, 2016 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 31, 2014 TCCA
REGISTERED-PRINCIPAL REGISTER
Feb 22, 2011 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 19, 2011 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Jan 18, 2011 REGV
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 5, 2011 EXRA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 4, 2011 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 4, 2011 SUPC
SOU EXTENSION 1 GRANTED
Jan 4, 2011 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 4, 2011 AITU
USE AMENDMENT FILED
Dec 7, 2010 IUAF
SOU EXTENSION 1 FILED
Dec 7, 2010 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 7, 2010 EEXT
TEAS STATEMENT OF USE RECEIVED
Dec 7, 2010 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 7, 2010 TCCA
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 8, 2010 NOAM
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 17, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 17, 2010 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 21, 2010 TCCA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 13, 2010 NPUB
PUBLISHED FOR OPPOSITION
Apr 13, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 6, 2010 PREV
ASSIGNED TO LIE
Mar 6, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 12, 2010 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2010 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 15, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 15, 2010 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 6, 2009 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 6, 2009 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 15, 2009 GNRN
NON-FINAL ACTION E-MAILED
Jul 15, 2009 GNRT
NON-FINAL ACTION WRITTEN
Jul 15, 2009 CNRT
ASSIGNED TO EXAMINER
Jul 7, 2009 DOCK
NOTICE OF PSEUDO MARK MAILED
Apr 22, 2009 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 21, 2009 NWOS
NEW APPLICATION ENTERED
Apr 21, 2009 NWAP

Related Trademarks

More from this Owner

NEUROSLEEP

NEUROSLEEP

NEUROSLEEP

NEUROSLEEP

NEUROSLEEP

NEUROSLEEP

NEUROSLEEP

NEUROSLEEP

NEUROSLEEP

NEUROSLEEP

NEUROSLEEP

NEUROSLEEP